Network Pharmacology-Based Strategy to Explore the Effect and Mechanism of Zhizhu Granule Improving Glucose-Lipid Metabolism in Rats with Metabolic Syndrome
Jiali Wang,Yiqing Liu,Chengkui Xiu,Xue Wang,Yinan Liu,Yanhong Hu,Jing Yang,Yan Lei
DOI: https://doi.org/10.2147/dmso.s477410
2024-10-19
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Jiali Wang, 1, 2 Yiqing Liu, 3 Chengkui Xiu, 1 Xue Wang, 1 Yinan Liu, 1 Yanhong Hu, 1 Jing Yang, 1 Yan Lei 1 1 Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; 2 Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, People's Republic of China; 3 National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China Correspondence: Yan Lei; Jing Yang, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China, Tel +13651217893 ; +15901070286, Email ; Objective: To explore the mechanism of the traditional Chinese medicine (TCM), Zhizhu granule (ZZG), in treating metabolic syndrome (MS) based on network pharmacology and pharmacodynamic experiment. Materials and Methods: Network pharmacology combined with a pharmacodynamic experiment was used to elucidate the therapeutic mechanism of ZZG in MS. Serum samples were collected from rats with MS, induced by a high-sugar-fat-salt diet (HSFSD) combined with streptozotocin (STZ), to measure the levels of biochemical markers. The glucose (GLU), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were detected. The liver tissue of rats was used for histological examination and Western blot analysis. Results: Network pharmacology analysis generated 69 drug-disease common targets and 10 hub genes closely related to ZZG against MS. KEGG pathway analysis revealed that the PI3K/AKT signaling pathway was the most potential pathway, which took part in the therapeutic mechanisms. In the animal experiments section, the therapeutic effect of ZZG on MS and the therapeutic pathway of ZZG on MS were verified. ZZG could significantly decrease the body weight, TC, TG, LDL-C and GLU levels in MS rats (all p < 0.01), alleviate hepatocyte steatosis and decrease liver lipid droplet deposition. Western blot analysis indicated that compared with the model group, the expression levels of PI3K, AKT, and IRS-1 protein were significantly increased (all p < 0.05), and the FOXO-1 was significantly decreased (all p < 0.05) in the ZZG group. Conclusion: ZZG can improve glucose-lipid metabolism disorder in rats with metabolic syndrome. The reported results provide experimental evidence for ZZG in the treatment of MS. Keywords: metabolic syndrome, network pharmacology, Zhizhu granule, pharmacodynamic experiment, PI3K/AKT pathway Metabolic syndrome (MS) is a complex syndrome that includes obesity, hypertension, hyperglycemia, and dyslipidemia. In 2005, the International Diabetes Foundation (IDF) published new criteria for metabolic syndrome. The content of the criteria includes: a. central obesity (waist circumference): ≥94 cm(M), ≥80cm(F); b. obesity, plus two of the four criteria below; c. fasting glucose ≥100mg/dl; d. TG ≥150mg/dl or Rx; e. HDL cholesterol: <40mg/dl(M), 130mmHg systolic or >85mmHg diastolic or Rx. 1 In addition to a healthy lifestyle, Butyrate, Probiotics, Asymmetric Dimethylarginine, Curcumin, Statins and other drugs can be truly used as a coadjuvant therapy for this pathology. 2 According to existing reports, the prevalence of MS in adults worldwide is about 20%-25%, 3 reaching up to 34.7% in the United States, and the prevalence tends to increase with age, affecting ever younger individuals. 4 It may increase the risk of cardiovascular diseases and type 2 diabetes mellitus approximately 2-fold and 5-fold or more, respectively. 5 In addition, hyperuricemia, thyroid dysfunction and non-alcoholic fatty liver disease are significantly associated with the development and severity of the metabolic syndrome. 6–8 Also, several studies support a possible negative impact of MS on male reproductive potential, reporting a negative association between MS and sperm parameters, testosterone and follicle-stimulating hormone levels. 9 MS is becoming a serious clinical and public health challenge, requiring greater attention. Traditional Chinese medicine (TCM) hold that the occurrence of MS is caused by the dysfunction of the kidney, liver and spleen, and is related to drinking, sitting for a long time, eating fat and sweet taste and insomnia, so it produces phlegm dampness, blood stasis, Qi deficiency, Yang deficiency, Yin deficiency and other syndromes. The treatment needs to apply Chinese herbs to regulate th -Abstract Truncated-
endocrinology & metabolism